BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35137110)

  • 21. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.
    Williams EJ; Mair L; de Silva TI; Green DJ; House P; Cawthron K; Gillies C; Wigfull J; Parsons H; Partridge DG
    J Hosp Infect; 2021 Apr; 110():103-107. PubMed ID: 33484783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in hospital antibiotic utilization during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter interrupted time-series analysis.
    Elligsen M; Wan M; Lam PW; Lo J; Taggart LR; Chan AJ; Downing M; Gough K; Seah J; Leung E
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e128. PubMed ID: 36483375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity).
    DeSear KE; Thompson-Leduc P; Van Schooneveld TC; Kirson N; Chritton JJ; Ie S; Cheung HC; Ou S; Zimmer L; Schuetz P
    Curr Med Res Opin; 2021 May; 37(5):727-733. PubMed ID: 33617362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic Usage in the COVID-19 Intensive Care Unit of an Infectious Diseases Hospital from Nord-Eastern Romania.
    Vâţă A; Roşu FM; Dorneanu OS; Lehaci AE; Luca Ş; Loghin II; Miftode ID; Luca CM; Miftode EG
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109601
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of COVID-19 on corticosteroids and antibiotics prescribing in England: an interrupted time series analysis.
    Chalitsios CV; McKeever TM; Langley TE; Shaw DE
    J Public Health (Oxf); 2021 Sep; 43(3):517-520. PubMed ID: 33539527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of restricting procalcitonin measurements in a Swiss tertiary-care hospital on antibiotic use, clinical outcomes, and costs: An interrupted time-series analysis.
    Abbas M; Vernaz N; von Dach E; Vuilleumier N; Harbarth SJ; Huttner BD
    Infect Control Hosp Epidemiol; 2021 Jul; 42(7):890-892. PubMed ID: 33261687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
    Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
    J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of medication safety incidents with antibiotic use measured by defined daily doses.
    Hamad A; Cavell G; Wade P; Hinton J; Whittlesea C
    Int J Clin Pharm; 2013 Oct; 35(5):772-9. PubMed ID: 23794077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    Sulis G; Batomen B; Kotwani A; Pai M; Gandra S
    PLoS Med; 2021 Jul; 18(7):e1003682. PubMed ID: 34197449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community antibiotic prescribing in patients with COVID-19 across three pandemic waves: a population-based study in Scotland, UK.
    Ciaccio L; Donnan PT; Parcell BJ; Marwick CA
    BMJ Open; 2024 Apr; 14(4):e081930. PubMed ID: 38643000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the five rights antibiotic safety before and during COVID-19 at an NHS Foundation Trust in the United Kingdom.
    Elshenawy RA; Umaru N; Aslanpour Z
    J Glob Antimicrob Resist; 2024 Mar; 36():188-189. PubMed ID: 38181880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
    Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
    Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shielding, hospital admission and mortality among 1216 people with total laryngectomy in the UK during the COVID-19 pandemic: A cross-sectional survey from the first national lockdown.
    Govender R; Behenna K; Brady G; Coffey M; Babb M; Patterson JM
    Int J Lang Commun Disord; 2021 Sep; 56(5):1064-1073. PubMed ID: 34351676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Accuracy of Procalcitonin upon Emergency Department Admission during SARS-CoV-2 Pandemic.
    Malinverni S; Lazzaroni S; Nuňez M; Preseau T; Cotton F; Martiny D; Bouazza F; Collot V; Konopnicki D; Alard S; Bartiaux M
    Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study.
    Hussein RR; Rabie ASI; Bin Shaman M; Shaaban AH; Fahmy AM; Sofy MR; Lattyak EA; Abuelhana A; Naguib IA; Ashour AM; Aldeyab MA
    J Infect Dev Ctries; 2022 Nov; 16(11):1679-1686. PubMed ID: 36449638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic use in township hospitals during the COVID-19 pandemic in Shandong, China.
    Wang T; Shen L; Yin J; Zhou L; Sun Q
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):164. PubMed ID: 36566210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit.
    Wang X; Long Y; Su L; Zhang Q; Shan G; He H
    Front Cell Infect Microbiol; 2022; 12():844134. PubMed ID: 35360102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials.
    Schuetz P; Bolliger R; Merker M; Christ-Crain M; Stolz D; Tamm M; Luyt CE; Wolff M; Schroeder S; Nobre V; Reinhart K; Branche A; Damas P; Nijsten M; Deliberato RO; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Beishuizen A; de Jong E; Briel M; Welte T; Mueller B
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):555-564. PubMed ID: 29969320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis.
    Kurdi A; Platt N; Morrison A; Proud E; Gronkowski K; Mueller T; Seaton RA; Malcolm W; Bennie M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):455-475. PubMed ID: 36803370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.